Highlights on the Development, Related Patents, and Prospects of Lenacapavir: The First-in-Class HIV-1 Capsid Inhibitor for the Treatment of Multi-Drug-Resistant HIV-1 Infection

  • Tafadzwa Dzinamarira
  • , Mazen Almehmadi
  • , Ahad Amer Alsaiari
  • , Mamdouh Allahyani
  • , Abdulelah Aljuaid
  • , Abdulaziz Alsharif
  • , Abida Khan
  • , Mehnaz Kamal
  • , Ali A. Rabaan
  • , Amal H. Alfaraj
  • , Bashayer M. AlShehail
  • , Nouf Alotaibi
  • , Shams M. AlShehail
  • , Mohd Imran

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Highlights on the Development, Related Patents, and Prospects of Lenacapavir: The First-in-Class HIV-1 Capsid Inhibitor for the Treatment of Multi-Drug-Resistant HIV-1 Infection'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science